Next Article in Journal
Antibody Drug Conjugates as Cancer Therapeutics
Next Article in Special Issue
Selection and Characterization of Single Domain Antibodies Specific for Bacillus anthracis Spore Proteins
Previous Article in Journal
An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells
Previous Article in Special Issue
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Article Menu

Export Article

Open AccessArticle
Antibodies 2013, 2(1), 93-112;

Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine

Department of Chemistry, Biotechnology and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-24 Korimoto, Kagoshima, Kagoshima 890-8580, Japan
Genenet CO., LTD. 5-22-8 Tanotsu, Higashi-ku, Fukuoka 813-0034, Japan
Faculty of Environmental Studies, Nagasaki University, 1-14 Bunkyou-machi, Nagasaki 852-8521, Japan
Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, 3-1-100 Tsukide, Kumamoto 862-8502, Japan
Author to whom correspondence should be addressed.
Received: 10 December 2012 / Revised: 9 January 2013 / Accepted: 5 February 2013 / Published: 7 February 2013
(This article belongs to the Special Issue Single-Domain Antibody)
PDF [747 KB, uploaded 7 February 2013]


An immune phage library derived from mice, hyperimmunized with morphine-conjugated BSA, was used to isolate a single-chain Fv (scFv) clone, M86, with binding activity to morphine-conjugated thyroglobulin (morphine-C-Tg) but not to codeine-, cocaine-, or ketamine-conjugated Tg. Surface plasmon resonance analysis using a morphine-C-Tg-coupled CM5 sensor chip showed that the Kd value was 1.26 × 108 M. To analyze its binding activity to free morphine and related compounds, we performed a competitive ELISA with M86 and morphine-C-Tg in the absence or presence of varying doses of free morphine and related compounds. IC50 values for opium, morphine, codeine, and heroin were 257 ng/mL, 36.4, 7.3, and 7.4 nM, respectively. Ketamine and cocaine exhibited no competitive binding activity to M86. Thus, we established a phage library-derived scFv, M86, which recognized not only free morphine and codeine as opium components but also heroin. This characteristic of M86 may be useful for developing therapeutic reagents for opiate addiction and as a free morphine-specific antibody probe. View Full-Text
Keywords: morphine; narcotic; hapten; single-chain Fv (scFv); recombinant antibody technology morphine; narcotic; hapten; single-chain Fv (scFv); recombinant antibody technology

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Matsukizono, M.; Kamegawa, M.; Tanaka, K.; Kohra, S.; Arizono, K.; Hamazoe, Y.; Sugimura, K. Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine. Antibodies 2013, 2, 93-112.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top